MYND.F Stock Overview
A life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
MYND Life Sciences Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.068 |
| 52 Week High | CA$0.068 |
| 52 Week Low | CA$0.013 |
| Beta | 0.41 |
| 11 Month Change | n/a |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | -77.40% |
| 5 Year Change | n/a |
| Change since IPO | -90.82% |
Recent News & Updates
Recent updates
Shareholder Returns
| MYND.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 3.4% | 1.6% |
| 1Y | n/a | 14.2% | 32.3% |
Return vs Industry: Insufficient data to determine how MYND.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how MYND.F performed against the US Market.
Price Volatility
| MYND.F volatility | |
|---|---|
| MYND.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.0% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MYND.F's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: Insufficient data to determine MYND.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Jay Campbell | www.myndsciences.com |
MYND Life Sciences Inc., a life sciences-based neuro-pharmaceutical drug development company, advances medicines based on neuro-anti-inflammatory substances for depressive disorders through science and clinical trials in Canada and the United States. It focuses on the analysis of psilocin and psilocybin extracts, and analogs. MYND Life Sciences Inc. is based in Port Coquitlam, Canada.
MYND Life Sciences Inc. Fundamentals Summary
| MYND.F fundamental statistics | |
|---|---|
| Market cap | US$1.87m |
| Earnings (TTM) | -US$385.46k |
| Revenue (TTM) | US$0.71 |
Over9,999x
P/S Ratio-4.8x
P/E RatioIs MYND.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| MYND.F income statement (TTM) | |
|---|---|
| Revenue | CA$1.00 |
| Cost of Revenue | CA$331.78k |
| Gross Profit | -CA$331.78k |
| Other Expenses | CA$210.79k |
| Earnings | -CA$542.56k |
Last Reported Earnings
Jul 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.011 |
| Gross Margin | -33,177,800.00% |
| Net Profit Margin | -54,256,500.00% |
| Debt/Equity Ratio | -50.1% |
How did MYND.F perform over the long term?
See historical performance and comparison